Stimulation of melanogenesis by scoparone in B16 melanoma cells

Acta Pharmacologica Sinica

Volumn 27, Issue 11, 2006, Pages 1467-1473

  Yang, Jeong Yeh ^a   Koo, Jeung Hyun ^a   Song, Young Gil ^a   Kwon, Kang Beom ^b   Lee, Ju Hyung ^a   Sohn, Hee Sook ^a   Park, Byung Hyun ^a   Jhee, Eun Chung ^a   Park, Jin Woo ^a  

^a Chonbuk National University   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Melanogenesis; Protein kinase A; Scoparone (6,7 dimethoxy coumarin); Tyrosinase; Tyrosinase related proteins

Indexed keywords

COUMARIN; CYCLIC AMP; ESCULETIN; HERNIARIN; MELANIN; MONOPHENOL MONOOXYGENASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SCOPARONE; SCOPOLETIN; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2; UMBELLIFERONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; MELANOGENESIS; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; COUMARINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRAMOLECULAR OXIDOREDUCTASES; ISOQUINOLINES; MELANINS; MELANOMA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES;

EID: 33750351969     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00435.x     Document Type: Article

References (33)

1. Hearing VJ. Regulation of melanin formation. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, editors. The pigmentary system: physiology and pathophysiology. New York: Oxford University Press; 1998. p423-38.
2. del Marmol V, Beermann F. Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett 1996; 381: 165-8.
3. Hearing VJ, Jimenez M. Mammalian tyrosinase-the critical regulatory control point in melanocyte pigmentation. Int J Biochem 1987; 19: 1141-7.
4. Yokoyama K, Yasumoto K, Suzuki H, Shibahara S. Cloning of the human DOPAchrome tautomerase/tyrosinase-related protein 2 gene and identification of two regulatory regions required for its pigment cell-specific expression. J Biol Chem 1994; 269: 27080-7.
5. Kobayashi T, Urabe K, Winder A, Jimenez-Cervantes C, Imokawa G, Brewington T, et al. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994; 13: 5818-25.
6. Egan D, O'kennedy R, Moran E, Cox D, Prosser E, Thornes RD. The pharmacology, metabolism, analysis and applications of coumarin and coumarin-related compounds. Drug Metabol 1990; 22: 503-29.
7. Huang HC, Chu SH, Lee Chao PD. Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur J Pharmacol 1991; 198: 211-3.
8. Huang HC, Huang YL, Chang JL, Chen CC, Lee YT. Possible mechanism of immunosuppressive effect of scoparone (6,7-dimethoxycoumarin). Eur J Pharmacol 1992; 217: 143-8.
9. Huang HC, Lee CR, Weng YI, Lee MC, Lee YT. Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb. Eur J Pharmacol 1992; 218: 123-8.
10. Huang HC, Weng YI, Lee CR, Jan TR, Chen YL, Lee YT. Protection by scoparone against the alterations of plasma lipoproteins, vascular morphology and vascular reactivity in hyperlipidaemic diabetic rabbit. Br J Pharmacol 1993; 110: 1508-14.
11. Mennes WC, Luijckx NB, Wortelboer HM, Noordhoek J, Blaauboer BJ. Differences in the effects of model inducers of cytochrome P450 on the biotransformation of scoparone in rat and hamster liver. Arch Toxicol 1993; 67: 92-7.
12. Hoult JR, Paya M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol 1996; 27: 713-22.
13. Ando H, Ryu A, Hashimoto A, Oka M, Ichihashi M. Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin. Arch Dematol Res 1998; 290: 375-81.
14. Jung GD, Yang JY, Song ES, Park JW. Stimulation of melanogenesis by glycyrrhizin in B16 melanoma cells. Exp Mol Med 2001; 33: 131-5.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
16. Lerch K. Monophenol monooxygenase from Neurospora crassa. Methods Enzymol 1987; 142: 165-9.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
19. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 1990; 265: 5267-72.
20. Nagata H, Takekoshi S, Takeyama R, Homma T, Yoshiyuki Osamura R. Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes. Pigment Cell Res 2004; 17: 66-73.
21. Masamoto Y, Murata Y, Baba K, Shimoishi Y, Tada M, Takahata K. Inhibitory effects of esculetin on melanin biosynthesis. Biol Pharm Bull 2004; 27: 422-5.
22. Hearing VJ. Biochemical control of melanogenesis and melanosomal organization. J Investig Dermatol Symp Proc 1999; 4: 24-8.
23. Pawelek JM, Chakraborty AK. The enzymology of melanogenesis. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, editors. The pigmentary system: physiology and pathophysiology. New York: Oxford University Press; 1998. p391-400.
24. Busca R, Ballotti R. Cyclic AMP, a key messenger in the regulation of skin pigmentation. Pigment Cell Res 2000; 13: 60-9.
25. Park HY, Gilchrest BA. Signaling pathways mediating melanogenesis. Cell Mol Biol 1999; 45: 919-30.
26. Romero-Graillet C, Aberdam E, Biagoli N, Massabni W, Ortonne JP, Ballotti R. Ultraviolet B radiation acts through the nitric oxide and cGMP sigmal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem 1996; 271: 28052-6.
27. Romero-Graillet C, Aberdam E, Clement M, Ortonne JP, Ballotti R. Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest 1997; 99: 635-42.
28. Lee J, Jung E, Park J, Jung K, Park E, Kim J, et al. Glycyrrhizin induces melanogenesis by elevating a cAMP level in B16 melanoma cells. J Invest Dermatol 2005; 124: 405-11.
29. Englaro W, Bahadoran P, Bertolotto C, Busca R, Derijard B, Livolsi A, et al. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation. Oncogene 1999; 18: 1553-9.
30. Jang SI, Kim YJ, Kim HJ, Lee JC, Kim HY, Kim YC, et al. Scoparone inhibits PMA-induced IL-8 and MCP-1 production through suppression of NF-kappaB activation in U937 cells. Life Sci 2006; 78: 2937-43.
31. Levy S. Dihydroxyacetone-containing sunless or self-tanning lotions. J Am Acad Dermatol 1992; 27: 989-93.
32. Levy S. Tanning preparations. Dermatol Clin 2000; 18: 591-6.
33. Fesq H, Brockow K, Strom K, Mempel M, Ring J, Abeck D. Dihydroxyacetone in a new formulation - a powerful therapeutic option in vitiligo. Dermatology 2001; 203: 241-3.